发明名称 |
A stable pharmaceutical formulation comprising torsemide modification II |
摘要 |
<p>Novel, stable pharmaceutical formulations for the oral administration of high purity torsemide modification II are disclosed. These formulations release high purity torsemide modification II in water at a constant and high purity rate, and the high purity torsemide modification II therein does not rearrange to torsemide modification I over time. Methods for their manufacture are also disclosed.</p> |
申请公布号 |
SK11632003(A3) |
申请公布日期 |
2004.04.06 |
申请号 |
SK20030001163 |
申请日期 |
2001.02.21 |
申请人 |
TEVA PHARMACEUTICAL INDUSTRIES LTD. |
发明人 |
LEIBOVICI MINUTZA;TENENGAUZER RUTH;KOPEL MIRA;ARONHIME JUDITH;KORDOVA MARCO |
分类号 |
A61K9/20;A61K;A61K31/44;A61K47/12;A61K47/26;A61K47/32;A61K47/38;A61P7/10;A61P9/00;A61P9/12;(IPC1-7):A61K31/44 |
主分类号 |
A61K9/20 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|